Cocrystal Pharma (COCP) Return on Sales (2010 - 2026)

Cocrystal Pharma (COCP) reported Return on Sales of 0.1% for Q1 2026, down 249.89% sequentially from 0.03% in Q4 2020.

Cocrystal Pharma (COCP) Return on Sales (2010 - 2026) Analysis & Trends

Cocrystal Pharma (COCP) has 8 years of Return on Sales data on file, last reported at 0.1% in Q1 2026.

For the quarter ending Q1 2026, Return on Sales changed N/A year-over-year to 0.1%; the trailing twelve-month figure through Mar 2026 stood at 0.06% (changed N/A YoY), and the FY2020 full-year result was 0.05%, up 3.0% from the prior year.
Return on Sales fell to 0.1% in Q1 2026, from 0.03% in the prior quarter.
In the past five years, Return on Sales ranged from a high of 0.1% in Q1 2026 to a low of 0.1% in Q1 2026.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROS (Qtr)
1	Oculis Holding AG	66,621.14 Bn	66,620.85 Bn	-	-
2	Nanobiotix	1,915.18 Bn	1,915.11 Bn	-	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	-
4	BeOne Medicines	471.27 Bn	466.48 Bn	1.35 Bn	0.00%
5	Vertex Pharmaceuticals	121.81 Bn	114.57 Bn	2.59 Bn	0.00%
6	Regeneron Pharmaceuticals	69.58 Bn	60.82 Bn	3.31 Bn	0.00%
7	Belite Bio	62.72 Bn	62.72 Bn	-	-
8	Argenx Se	55.51 Bn	50.33 Bn	1.41 Bn	0.00%
9	Revolution Medicines	37.35 Bn	37.35 Bn	-	-
10	Cocrystal Pharma	12.57 Mn	7.74 Mn	-	-0.10%

Historic Data

Download Data

Date	Value
Mar 31, 2026	-0.10%
Dec 31, 2020	-0.03%
Sep 30, 2020	-0.06%
Jun 30, 2020	-0.07%
Mar 31, 2020	-0.06%
Dec 31, 2019	-1.19%
Sep 30, 2019	-0.04%
Jun 30, 2019	-0.03%
Mar 31, 2019	0.01%
Dec 31, 2015	-11.99%
Sep 30, 2015	-0.26%
Jun 30, 2015	-0.93%
Mar 31, 2015	-10.86%
Jun 30, 2013	0.00%
Mar 31, 2013	-0.01%
Dec 31, 2012	0.00%
Sep 30, 2012	0.00%
Jun 30, 2012	0.00%
Mar 31, 2012	-0.01%
Dec 31, 2011	-0.01%